Nasdaq: RNXT/Biotechnology
RenovoRx, Inc.
Mountain View, CA, United States
Company overview
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in developing targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. The company was founded in 2009 and is headquartered in Mountain View, California.
This profile is for informational purposes only and is not investment advice. Company information may change after the verification date.